Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse lymphnode metabolome response to West Nile Virus (WNV)

ABSTRACT: Metabolomics data from mouse lymphnodes; Treated with wild-type and mutant WNV, and mockulum

INSTRUMENT(S): GC MS

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

SUBMITTER: Yoshihiro Kawaoka, Katrina Waters, Michael Diamond, Richard Smith and Thomas Metz

PROVIDER: MSV000080021 | MassIVE | Thu Aug 04 12:14:00 BST 2016

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Publications

The clinical-forensic dichotomy in sexual abuse evaluations: moving toward an integrative model.

Tishelman Amy C AC Meyer Susanne K SK Haney Penny P McLeod Sara K SK

Journal of child sexual abuse 20100901 5

We propose the use of an approach to evaluation that can be undertaken in a clinical setting when concerns regarding child sexual abuse are unclear or ambiguous and other systems are not involved, thus providing an option for the nondisclosing child often discussed in the "delayed disclosure" literature. This approach can also be appropriate for a child with a questionable prior disclosure not being served by other intervention systems. We have labeled this an "integrative" model, incorporating ...[more]

PMID: 20924912

Similar Datasets

Mouse cortex metabolome response to West Nile Virus (WNV)

Project description:Metabolomics data from mouse cortex; Treated with wild-type and mutant WNV, and mockulum

2016-08-04 | MSV000080019 | MassIVE

Mouse cerebellum metabolome response to West Nile Virus (WNV)

Project description:Metabolomics data from mouse cerebellum; Treated with wild-type and mutant WNV, and mockulum

2016-08-04 | MSV000080020 | MassIVE

Mouse cortical neuron transcriptional response to wild-type West Nile virus (WNV-NY) and mutant virus WNV E218A [mRNA]

Project description:The purpose is to obtain samples for transcriptional analysis in triplicate wells using wild type West Nile virus (WNV NY99 clone 382; WNVWT) and mutant virus (WNVE218A) in mouse cortical neurons. This data set comprises two complete biological replicate experiments conducted in the same conditions and with data processed independently. Primary cortical neurons from C57Bl/6J mouse embryos (age E15) are infected with plasmid-derived wild type West Nile virus NY99 clone 382 (WNVWT) or plasmid-derived isogenic E218A mutant West Nile virus NY99 clone 382 (WNVE218A) with multiplicity of infection (MOI) 250. Three technical replicates were performed at each of 1, 8, 12 and 24 hrs post infection. Time matched mocks done in triplicate are treated with mockulum: cell media concentrated through ultracentrifugation and diluted as virus. mRNA is sampled at all time points; microRNA is sampled at 12 hours post-infection. There were two independent biological replicates of the entire procedure, distinguished by sample name prefixes ('WCN002' and 'WCN003') and the biological_replicate characteristic field.

2015-04-04 | E-GEOD-67473 | biostudies-arrayexpress

Mouse cerebellum proteomics response to West Nile Virus (WNV)

Project description:Proteomics data from mouse cerebellum; Treated with wild-type and mutant WNV, and mockulum

2016-11-28 | MSV000080360 | MassIVE

Mouse lymphnode proteomics response to West Nile Virus (WNV)

Project description:Proteomics data from mouse lymphnodes; Treated with wild-type and mutant WNV, and mockulum

2016-08-04 | MSV000080024 | MassIVE

Mouse cortex proteomics response to West Nile Virus (WNV)

Project description:Proteomics data from mouse cortex; Treated with wild-type and mutant WNV, and mockulum

2016-11-28 | MSV000080361 | MassIVE

Mouse lymphnode lipidomics response to West Nile Virus (WNV)

Project description:Lipidomics data from mouse lymphnodes; Treated with wild-type and mutant WNV, and mockulum

2016-11-24 | MSV000080354 | MassIVE

Mouse granule cell neuron transcriptional response to wild-type West Nile virus (WNV-NY) and mutant virus WNV E218A (mRNA)

Project description:The purpose is to obtain samples for transcriptional analysis in triplicate wells using wild type West Nile virus (WNV NY99 clone 382; WNVWT) and mutant virus (WNVE218A) in mouse granule cell neurons. This data set comprises two complete biological replicate experiments conducted in the same conditions and with data processed independently. Granule cell neurons from day 6 C57Bl/6J mouse pups are infected with plasmid-derived wild type West Nile virus NY99 clone 382 (WNVWT) or plasmid-derived isogenic E218A mutant West Nile virus NY99 clone 382 (WNVE218A) with multiplicity of infection (MOI) 250. Three technical replicates were performed at each of 1, 8, 12 and 24 hrs post infection. Time matched mocks done in triplicate are treated with mockulum: cell media concentrated through ultracentrifugation and diluted as virus. mRNA is sampled at all time points; microRNA is sampled at 12 hours post-infection. There were two independent biological replicates of the entire procedure, distinguished by sample name prefixes ('WGCN002' and 'WGCN003') and the biological_replicate characteristic field.

2015-04-29 | E-GEOD-68380 | biostudies-arrayexpress

Mouse granule cell neuron transcriptional response to wild-type West Nile virus (WNV-NY) and mutant virus WNV E218A (microRNA)

Project description:The purpose is to obtain samples for transcriptional analysis in triplicate wells using wild type West Nile virus (WNV NY99 clone 382; WNVWT) and mutant virus (WNVE218A) in mouse granule cell neurons. This data set comprises two complete biological replicate experiments conducted in the same conditions and with data processed independently. Granule cell neurons from day 6 C57Bl/6J mouse pups are infected with plasmid-derived wild type West Nile virus NY99 clone 382 (WNVWT) or plasmid-derived isogenic E218A mutant West Nile virus NY99 clone 382 (WNVE218A) with multiplicity of infection (MOI) 250. Three technical replicates were performed at each of 1, 8, 12 and 24 hrs post infection. Time matched mocks done in triplicate are treated with mockulum: cell media concentrated through ultracentrifugation and diluted as virus. mRNA is sampled at all time points; microRNA is sampled at 12 hours post-infection. There were two independent biological replicates of the entire procedure, distinguished by sample name prefixes ('WGCN002' and 'WGCN003') and the biological_replicate characteristic field.

2015-04-29 | E-GEOD-68381 | biostudies-arrayexpress